Exploring Support for Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus (SLE) is a complex autoimmune condition that affects multiple systems in the body. People living with lupus often face chronic inflammation, immune dysregulation, and a wide range of symptoms—from fatigue and joint pain to more serious organ involvement. Because SLE is multifactorial and unique to each individual, many patients and practitioners explore complementary approaches that may support overall wellness alongside standard care.

One area of growing interest is the role of systemic enzymes, such as nattokinase and serrapeptase, which are found in advanced formulations like Serracor-NK.

 

---

What Is Serracor-NK?

Serracor-NK is a professional-grade systemic enzyme blend designed to support healthy circulation, balanced inflammatory responses, and normal fibrin metabolism. It typically combines enzymes such as:

• Nattokinase – derived from the traditional Japanese food natto, known for its fibrinolytic (fibrin-breaking) activity.

• Serrapeptase – a proteolytic enzyme studied for its ability to support inflammatory balance.

• Co-factors and antioxidants – nutrients that aid in protecting cells from oxidative stress.

Together, these ingredients are formulated to promote vascular health, maintain healthy blood viscosity, and encourage the body’s natural clean-up processes.

---

Why Enzymes Are Being Considered in Autoimmune Conditions

In SLE and other autoimmune diseases, the immune system mistakenly attacks healthy tissues, creating cycles of inflammation and tissue damage. Systemic enzymes are being studied for their potential to:

• Support balanced immune responses – rather than overstimulating the immune system, enzymes may help regulate it.

• Encourage healthy circulation – by targeting excess fibrin and promoting microcirculation.

• Reduce oxidative stress – an underlying factor in many autoimmune flares.

• Aid recovery and tissue repair – by helping the body clear cellular debris more efficiently.

While systemic enzymes are not a treatment or cure for lupus, many practitioners explore them as part of a wellness plan to help improve quality of life and overall resilience.

---

Nattokinase and Lupus: What We Know

Research specific to nattokinase and lupus is still limited. However, studies on nattokinase suggest benefits in areas that overlap with lupus management goals:

• Cardiovascular health – people with lupus face higher cardiovascular risks. Nattokinase may help maintain healthy blood pressure and circulation.

• Fibrin breakdown – excessive fibrin can contribute to poor blood flow and inflammation.

• Inflammatory pathways – while more research is needed, some studies indicate systemic enzymes may help modulate inflammatory cascades.

It’s important to note that these findings are preliminary and not lupus-specific. Anyone with SLE considering Serracor-NK or nattokinase should consult a healthcare provider first, especially since autoimmune patients often take immunosuppressants, blood thinners, or corticosteroids that may interact with supplements.

---

Safety Considerations

Because lupus is a highly individualized condition, safety is key. Points to keep in mind:

• Medication interactions – nattokinase may have mild blood-thinning effects; combining with anticoagulants could increase risk.

• Immune regulation – lupus patients on immuno~suppressants should speak with their rheumatologist before adding systemic enzymes.

• Start slow – many practitioners recommend gradual introduction and close monitoring of response.

 

 

Direct orders will save 10% & get free shipping  

 

Here is how:

Click Buy now below or on our sidebar OR Send us an email 
1. Email orders to ASKAboutVitamins@gmail.com 

2. State the product & quantity

3.We send you an invoice from Paypal (which is secure & offers buyer protection)

4. Once the invoice is paid, we ship (for free) the same day

 

 Email orders to ASKAboutVitamins@GMAIL.com

#Fibromyalgia

 

 

 

 Use this above "BUY Now" to direct order and pay $112 with Free Shipping (msrp $124.99)

More than one item use Add to Cart

 

Fibromyalgia 

Before the 70's, fibromyalgia was most commonly known as fibrositis, where “itis” implied an inflammatory component. Despite the understanding of inflammatory pathways to pain, clinical research was unable to identify the role of inflammation in fibromyalgia for many years.

Within the last decade, fibromyalgia research has once again been focusing on the possible contribution of inflammation to disease progression, and is finding some new and interesting results.

Clinical studies have produced evidence that fibromyalgia is associated with the immune system’s improper regulation of proinflammatory cytokines that circulate in the bloodstream, contributing to the dysfunction of the central nervous system and pain-related neurotransmitters. Cytokines, depending on their concentration, induce symptoms, such as fatigue, fever, sleep, pain, and muscle pain, all of which develop in fibromyalgia patients.

These findings are uncovering new possibilities in research for fibromyalgia causation, as well as treatment options. Some experimental pain reduction therapies have been examined and shown positive results, correlating with decreased proinflammatory cytokine levels. Anticonvulsant drugs, analgesics, opiods and anti-depressants are commonly prescribed to fibromyalgia patients, but tend to carry side effects reflective of the syndrome itself,and many of which lack evidence for effectiveness.

Limited treatment options have led to an increasing use of systemic enzyme therapy as a means to alleviate symptoms and improve quality of life. Certain proteolytic (protein digesting) enzymes have been identified to have extremely beneficial actions when applied to inflammation and pain related to this condition.

It has long been known that people with chronic muscle pain or fibromyalgia have more fibrin in their tissues and blood. This fibrin, while initially helpful in the early stages of healing after an injury, can become problematic if the body does not clear itself of the agent after it has done its work.

Fibromyalgia sufferers experience micro-tears in their muscles from the normal activity of daily living — each and every day. But because the average fibromyalgia patient does not achieve and stay in stage 4 delta sleep at rest, growth hormone is not produced in enough quantities to heal these tears, which leads to more fibrin buildup.

For the most part, people with fibromyalgia do not have a strong enzymatic capacity for producing enzymes that break down fibrin. This leads to a buildup of fibrin, which over time catches red blood cells in a web of restriction. This fibrin causes a restriction of blood flow. Red blood cells literally become stuck, disabling them from getting into the capillaries to oxygenate and nourish the muscles where the metabolic waste that causes pain is removed.

The body uses fibrin to help heal itself after an injury. However, if you have poor blood flow and a lack of enzyme activity, fibrin will start to accumulate. If the injured area is slow to heal, fibrin accumulation appears as clumps of scar tissue in the muscles or at a surgical site.

Ultimately, if excess fibrin is present throughout the circulatory system, blood flow is restricted to areas of the body that need it most. Over time, the body compensates for this restriction by increasing its blood pressure. People with excess fibrin suffer from chronic fatigue, slow healing, inflammation and pain, as well as elevated blood pressure.

Proteolytic enzymes taken on an empty stomach break down these proteins into their smallest elements. The enzymes pass through the stomach and intestinal lining, and enter the bloodstream where they begin the process of breaking down the buildup in the muscles, connective tissue and blood. These enzymes bring nutrition and oxygen-rich blood that can remove the metabolic waste produced by inflammation and excess fibrin.

Serrapeptase has been proven to be the strongest of the proteolytic enzymes, inducing anti-inflammatory, fibrinolytic and anti-edemic (prevents swelling and fluid retention) activity in a number of tissues.

Using enzymes to clear your body of fibrin takes time. It takes years to develop webs of fibrin in your tissues — so be patient, log your usage and, over time, notice how much less pain and how much more flexibility you have.